|
1
|
Jemal A, Siegel R, Ward E, et al: Cancer
statistics, 2008. CA Cancer J Clin. 58:71–96. 2008. View Article : Google Scholar
|
|
2
|
Sadahiro S, Suzuki T, Ishikawa K, et al:
Recurrence patterns after curative resection of colorectal cancer
in patients followed for a minimum of ten years.
Hepatogastroenterology. 50:1362–1366. 2003.PubMed/NCBI
|
|
3
|
Yamada H, Hirano S, Tanaka E, Shichinohe T
and Kondo S: Surgical treatment of liver metastases from pancreatic
cancer. HPB (Oxford). 8:85–88. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Suemizu H, Monnai M, Ohnishi Y, Ito M,
Tamaoki N and Nakamura M: Identification of a key molecular
regulator of liver metastasis in human pancreatic carcinoma using a
novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG)
mice. Int J Oncol. 31:741–751. 2007.PubMed/NCBI
|
|
5
|
Hamada K, Monnai M, Kawai K, et al: Liver
metastasis models of colon cancer for evaluation of drug efficacy
using NOD/Shi-scid IL2Rgammanull (NOG) mice. Int J Oncol.
32:153–159. 2008.PubMed/NCBI
|
|
6
|
Matsuyama M, Wakui M, Monnai M, et al:
Reduced CD73 expression and its association with altered purine
nucleotide metabolism in colorectal cancer cells robustly causing
liver metastases. Oncol Lett. 1:431–436. 2010.
|
|
7
|
Matsuo E, Watanabe M, Kuyama H and
Nishimura O: A new strategy for protein biomarker discovery
utilizing 2-nitrobenzenesulfenyl (NBS) reagent and its applications
to clinical samples. J Chromatogr B Analyt Technol Biomed Life Sci.
877:2607–2614. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Way JC and Chalfie M: mec-3, a
homeobox-containing gene that specifies differentiation of the
touch receptor neurons in C. elegans. Cell. 54:5–16. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Freyd G, Kim SK and Horvitz HR: Novel
cysteine-rich motif and homeodomain in the product of the
Caenorhabditis elegans cell lineage gene lin-11. Nature.
344:876–879. 1990. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Karlsson O, Thor S, Norberg T, Ohlsson H
and Edlund T: Insulin gene enhancer binding protein Isl-1 is a
member of a novel class of proteins containing both a homeo- and a
Cys-His domain. Nature. 344:879–882. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dawid IB, Breen JJ and Toyama R: LIM
domains: multiple roles as adapters and functional modifiers in
protein interactions. Trends Genet. 14:156–162. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng Q and Zhao Y: The diverse
biofunctions of LIM domain proteins: determined by subcellular
localization and protein-protein interaction. Biol Cell.
99:489–502. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pérez-Alvarado GC, Miles C, Michelsen JW,
et al: Structure of the carboxy-terminal LIM domain from the
cysteine rich protein CRP. Nat Struct Biol. 1:388–398.
1994.PubMed/NCBI
|
|
14
|
Schmeichel KL and Beckerle MC: The LIM
domain is a modular protein-binding interface. Cell. 79:211–219.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Heiss NS, Gloeckner G, Bächner D, et al:
Genomic structure of a novel LIM domain gene (ZNF185) in Xq28 and
comparisons with the orthologous murine transcript. Genomics.
43:329–338. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vanaja DK, Cheville JC, Iturria SJ and
Young CY: Transcriptional silencing of zinc finger protein 185
identified by expression profiling is associated with prostate
cancer progression. Cancer Res. 63:3877–3882. 2003.PubMed/NCBI
|
|
17
|
Zhang JS, Gong A and Young CY: ZNF185, an
actin-cytoskeleton-associated growth inhibitory LIM protein in
prostate cancer. Oncogene. 26:111–122. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Maul RS and Chang DD: EPLIN, epithelial
protein lost in neoplasm. Oncogene. 18:7838–7841. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tatarelli C, Linnenbach A, Mimori K and
Croce CM: Characterization of the human TESTIN gene localized in
the FRA7G region at 7q31.2. Genomics. 68:1–12. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tobias ES, Hurlstone AF, MacKenzie E,
McFarlane R and Black DM: The TES gene at 7q31.1 is methylated in
tumours and encodes a novel growth-suppressing LIM domain protein.
Oncogene. 20:2844–2853. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Visvader JE, Venter D, Hahm K, et al: The
LIM domain gene LMO4 inhibits differentiation of mammary epithelial
cells in vitro and is overexpressed in breast cancer. Proc Natl
Acad Sci USA. 98:14452–14457. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Song Y, Maul RS, Gerbin CS and Chang DD:
Inhibition of anchorage-independent growth of transformed NIH3T3
cells by epithelial protein lost in neoplasm (EPLIN) requires
localization of EPLIN to actin cytoskeleton. Mol Biol Cell.
13:1408–1416. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sum EY, Peng B, Yu X, et al: The LIM
domain protein LMO4 interacts with the cofactor CtIP and the tumor
suppressor BRCA1 and inhibits BRCA1 activity. J Biol Chem.
277:7849–7856. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Garvalov BK, Higgins TE, Sutherland JD, et
al: The conformational state of Tes regulates its zyxin-dependent
recruitment to focal adhesions. J Cell Biol. 161:33–39. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang B, Feng P, Xiao Z and Ren EC: LIM and
SH3 protein 1 (Lasp1) is a novel p53 transcriptional target
involved in hepatocellular carcinoma. J Hepatol. 50:528–537. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Grunewald TG, Kammerer U, Schulze E, et
al: Silencing of LASP-1 influences zyxin localization, inhibits
proliferation and reduces migration in breast cancer cells. Exp
Cell Res. 312:974–982. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Grunewald TG, Kammerer U, Winkler C, et
al: Overexpression of LASP-1 mediates migration and proliferation
of human ovarian cancer cells and influences zyxin localisation. Br
J Cancer. 96:296–305. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gonzalez HE, Gujrati M, Frederick M, et
al: Identification of 9 genes differentially expressed in head and
neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg.
129:754–759. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Medina PP, Carretero J, Ballestar E, et
al: Transcriptional targets of the chromatin-remodelling factor
SMARCA4/BRG1 in lung cancer cells. Hum Mol Genet. 14:973–982. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Taira M, Evrard JL, Steinmetz A and Dawid
IB: Classification of LIM proteins. Trends Genet. 11:431–432. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Benson AB III, Schrag D, Somerfield MR, et
al: American Society of Clinical Oncology recommendations on
adjuvant chemotherapy for stage II colon cancer. J Clin Oncol.
22:3408–3419. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Staib L, Link KH, Blatz A and Beger HG:
Surgery of colorectal cancer: surgical morbidity and five- and
ten-year results in 2400 patients - monoinstitutional experience.
World J Surg. 26:59–66. 2002.PubMed/NCBI
|
|
33
|
Schiffmann L, Eiken AK, Gock M and Klar E:
Is the lymph node ratio superior to the Union for International
Cancer Control (UICC) TNM system in prognosis of colon cancer?
World J Surg Oncol. 11:792013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sadahiro S, Suzuki T, Tanaka A, Okada K
and Kamata H: Hematogenous metastatic patterns of curatively
resected colon cancer were different from those of stage IV and
autopsy cases. Jpn J Clin Oncol. 43:444–447. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Baba H, Watanabe M, Okabe H, et al:
Upregulation of ERCC1 and DPD expressions after oxaliplatin-based
first-line chemotherapy for metastatic colorectal cancer. Br J
Cancer. 107:1950–1955. 2012. View Article : Google Scholar : PubMed/NCBI
|
